Back to search results

Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT

Abroad (travel likely)RecruitingPHASE4

Conditions

Type II Diabetes · Atherosclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute), Torrance, California, United States

    Contact: Study coordinator (Matthew Budoff, MD) · mbudoff@lundquist.org · 310-222-4107
    Contact: Study coordinator (Sajad Hamal, MS) · shamal@lundquist.org · 310-974-9336
    Contact: Principal Investigator (Matthew J Budoff, MD)
Study leads

  • Matthew A Budoff, MD

    Principal Investigator

    The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

View source on ClinicalTrials.gov(opens in a new tab)